Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leuKemia-lymphoma cells

细胞周期蛋白依赖激酶4 细胞周期 细胞周期蛋白依赖激酶2 激酶 细胞周期蛋白D1
作者
Hans G. Drexler
出处
期刊:Leukemia [Springer Nature]
卷期号:12 (6): 845-859 被引量:384
标识
DOI:10.1038/sj.leu.2401043
摘要

The cyclin-dependent kinase inhibitors known as p15, p16, p18 and p19 have been suggested as candidates for tumor suppressor genes. The main genetic alterations are deletions (bi- or monoallelic) or 5' CpG island methylation of p15 and p16; very few cases or cell lines had p18 or p19 deletions or hypermethylation. Hypermethylation and homozygous deletions of tumor suppressor genes establish a new paradigm of inactivation by lack of expression, in contrast to the previously identified tumor suppressors which are predominantly inactivated by point mutations followed by loss of the wild-type allele. Here, the literature data on alterations of this gene family in more than 4700 primary cases of leukemia or lymphoma and some 320 continuous leukemia-lymphoma cell lines are summarized. Among hematopoietic malignancies, the highest frequencies of p15del and p16del were seen in acute lymphoblastic leukemia (ALL) (>30%) with striking rates in T-ALL (>50%), but also high rates in B cell precursor (BCP)-ALL (>20%); the rates of deletions in chronic lymphoid leukemia (CLL), multiple myeloma, acute and chronic myeloid leukemia (AML and CML), and myelodysplastic syndromes (MDS) were rather low, only some B cell and T cell lymphomas showed increased frequencies. Results are quite different with regard to the second mode of inactivation, hypermethylation of the promoter region. Here, p15 is most often inactivated, at particularly high frequencies in the disorders lacking any p15/p16 deletions: 40-80% p15met in AML, MDS and multiple myeloma. Also p15met rates in BCP- and T-ALL cases were high (c. 40%). There is controversy concerning the prognostic impact of p15 and p16 aberrations with some studies describing a significant correlation between inactivation of these genes and poor prognosis, while most others did not detect any prognostic relevance, at least in pediatric ALL; there may be a worse prognosis for adults with B or T cell lymphomas. Despite the small number of cases studied, paired sequential analyses suggested that disease progression is associated with loss of p15/p16 activity in a certain percentage of adult patients. p15del/p16del and p15met/p16met were also detected in the large panel of leukemia-lymphoma cell lines studied. In general, the results in cell lines reproduce the data seen in primary cells with the important difference that the rates of p15/p16 inactivation are clearly higher in the cultured cells compared with the freshly explanted cells. Retrovirus- or electroporation-mediated ectopic gene transfer of p16 wild-type into p16-deficient cell lines led to growth inhibition, arrest in G1 (without apoptosis) and occasionally to differentiation, suggesting that the malignant phenotype of p16-/- cell lines can, at least partially, be reversed by restoring p16 gene expression. A striking inverse correlation between the absence of p16 (due to deletion) and presence of wild-type retinoblastoma gene was observed in cell lines confirming a common growth suppressor pathway; no comparable relationship of p16 inactivation with p53 was detected. Paired analysis of cell lines and corresponding primary cell material showed that in all instances tested both populations carried the same gene configuration of p15 and p16. Thus, p15del or p16del did not occur during establishment of the cell lines or during prolonged culture. It is likely that p15 or p16 deletions already acquired in vivo provide a dramatic growth advantage for the immortalization process in vitro, thus increasing the success rate for cell line establishment which is commonly extremely difficult. In conclusion, the present review suggests an involvement of the p15 and p16 tumor suppressor genes in leukemo- and lymphomagenesis. Future studies will determine their exact role in the development and progression of hematopoietic neoplasms. These genes may represent interesting targets for new therapeutic strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Fang Xianxin发布了新的文献求助10
1秒前
1秒前
2秒前
nanaki给Tt的求助进行了留言
2秒前
2秒前
3秒前
虚心的惮完成签到 ,获得积分10
4秒前
Frank完成签到 ,获得积分10
4秒前
烂漫人达完成签到 ,获得积分10
5秒前
Liang完成签到,获得积分10
6秒前
TC发布了新的文献求助10
7秒前
传奇3应助枕星采纳,获得10
7秒前
凡凡发布了新的文献求助10
8秒前
免疫与代谢研究完成签到,获得积分10
9秒前
jiajiajai发布了新的文献求助10
10秒前
西早07完成签到,获得积分10
10秒前
Meng完成签到,获得积分10
11秒前
Neo完成签到,获得积分10
12秒前
keyaner完成签到,获得积分10
14秒前
童林艳完成签到,获得积分10
14秒前
ECHO完成签到,获得积分10
16秒前
Lucas应助Fang Xianxin采纳,获得10
17秒前
xiaoyao完成签到,获得积分10
18秒前
asss完成签到,获得积分10
18秒前
Y123发布了新的文献求助30
19秒前
LOVER完成签到 ,获得积分10
20秒前
松松完成签到 ,获得积分10
20秒前
22秒前
nater4ver完成签到,获得积分10
23秒前
UU发布了新的文献求助10
25秒前
超帅鸭子完成签到,获得积分10
25秒前
LXZ完成签到,获得积分10
25秒前
依惜完成签到,获得积分10
25秒前
zhaokunfeng关注了科研通微信公众号
25秒前
赫青亦完成签到 ,获得积分10
25秒前
exy完成签到,获得积分10
26秒前
zhaohu47完成签到,获得积分10
27秒前
超帅鸭子发布了新的文献求助10
27秒前
每每反完成签到,获得积分10
29秒前
凡凡完成签到 ,获得积分10
30秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029